The Intelligence from The Economist cover image

Harms weigh: AstraZeneca vaccine fears

The Intelligence from The Economist

00:00

Intro

This chapter explores the backlash against the Oxford-AstraZeneca COVID-19 vaccine following reports of adverse effects, leading to suspensions in multiple European nations. It underscores the impact of these decisions on vaccination efforts amid escalating infection rates and highlights the urgency of restoring public confidence in vaccines.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner
Get the app